OpenLegislation

Regulation 139A Amendment of regulation 179 (obligation on licensing authority to operate pharmacovigilance system)F1I1

In regulation 179—

(a)

in paragraph (1), after “pharmacovigilance system” insert “in relation to medicinal products for sale or supply in Great Britain”;

(b)

after paragraph (1) insert—

“(1A)

The licensing authority must operate a pharmacovigilance system in relation to medicinal products for sale or supply in Northern Ireland.”;

(c)

in paragraph (2) for “The pharmacovigilance system” substitute “Each pharmacovigilance system”; and

(d)

in paragraph (3)(a) for “the pharmacovigilance system” substitute “each pharmacovigilance system”.

Annotations

Textual amendments

F1

Reg. 139A inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 108

Commencement

I1

Reg. 139A in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1